vimarsana.com

Latest Breaking News On - ஒன்றுபட்டது கிஂக்டம் தந்தி - Page 8 : vimarsana.com

【疫情7 21】研究:67%印度人有中共病毒抗体 | 疫苗 | COVID-19

【疫情7 21】研究:67%印度人有中共病毒抗体 | 疫苗 | COVID-19
epochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epochtimes.com Daily Mail and Mail on Sunday newspapers.

Britanija neće masovno vakcinisati tinejdžere

Britanija neće masovno vakcinisati tinejdžere
krstarica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from krstarica.com Daily Mail and Mail on Sunday newspapers.

Coronavirus Australia: COVID-19 vaccine made in Melbourne for AstraZeneca poses potential hurdles for European travel

Australians vaccinated with the AstraZeneca jab face potential problems visiting Europe, thanks to a quirk in the European Union s vaccine approval process. Despite the Aussie-made vaccine being identical to those made in Belgium, the Netherlands and the UK, it s not technically authorised in Europe because AstraZeneca hasn t registered CSL s Melbourne facility with the European drugs regulator. Facilities in the USA, Korea and even China have all been registered but the European Medicines Agency has confirmed the labs pumping out millions of doses in India and Australia haven t been registered. READ MORE: Melbourne s CSL facility used to make AstraZeneca in Australia has not been registered with the European Medicines Agency. Prime Minister Scott Morrison visited the facility in February.(Getty)

Disa prej tyre spiunuan gratë që pëlqenin , Facebook largoi nga puna 52 punonjës që po ndiqnin aktivitetet e përdoruesve

Disa prej tyre spiunuan gratë që pëlqenin , Facebook largoi nga puna 52 punonjës që po ndiqnin aktivitetet e përdoruesve
telegrafi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegrafi.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.